Establishment of N-acetylmannosamine (ManNAc) analogue-resistant cell lines as improved hosts for sialic acid engineering applications

Biotechnology Progress

Volumn 20, Issue 6, 2004, Pages 1674-1682

  Eun, Jeong Kim ^a,b   Jones, Mark B ^a   Jun, Kyu Rhee ^a   Sampathkumar, Srinivasa Gopalan ^a   Yarema, Kevin J ^a  

^a Johns Hopkins University   (United States)

^b UNIVERSITY OF MARYLAND BIOTECHNOLOGY INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODIES; BIOSYNTHESIS; CELLS; METABOLISM; ORGANIC ACIDS; REACTION KINETICS; SENSITIVITY ANALYSIS; SUBSTRATES;

APOPTOSIS; BIOSYNTHETIC PATHWAY; CELL SURFACES; SIALIC ACID ENGINEERING;

AMINES;

HEXOSAMINE; N ACETYLMANNOSAMINE; N ACETYLNEURAMINIC ACID; N-ACETYLMANNOSAMINE;

APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC ENHANCEMENT; GENETICS; HUMAN; LEUKEMIA CELL LINE; METHODOLOGY; SPECIES DIFFERENCE;

APOPTOSIS; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; GENE EXPRESSION REGULATION; GENETIC ENHANCEMENT; HEXOSAMINES; HUMANS; JURKAT CELLS; N-ACETYLNEURAMINIC ACID; SPECIES SPECIFICITY;

EID: 10044232836     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp049841q     Document Type: Article

References (38)

1. Kayser, H.; Zeitler, R.; Kannicht, C.; Grunow, D.; Nuck, R.; Reutter, W. Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. J. Biol. Chem. 1992, 267, 16934-16938.
2. Mahal, L. K.; Yarema, K. J.; Bertozzi, C. R. Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis. Science 1997, 276, 1125-1128.
3. Yarema, K. J.; Mahal, L. K.; Bruehl, R. E.; Rodriguez, E. C.; Bertozzi, C. R. Metabolic delivery of ketone groups to sialic acid residues. Application to cell surface glycoform engineering. J. Biol. Chem. 1998, 273, 31168-31179.
4. Villaviecencio-Lorini, P.; Laabs, S.; Danker, K.; Reutter, W.; Horstkorte, R. Biochemical engineering of the acyl side chain of sialic acids stimulates integrin-dependent adhesion of HL60 cells to fibronectin. J. Mol. Med. 2002, 80, 671-677.
5. Wieser, J. R.; Heisner, A.; Stehling, P.; Oesch, R.; Reutter, W. In vivo modulated N-acyl side chain of N-acetylneuraminic acid modulates the cell-dependent inhibition of growth. FEBS Lett. 1996, 395, 170-173.
6. Lemieux, G. A.; Bertozzi, C. R. Modulating cell surface immunoreactivity by metabolic induction of unnatural carbohydrate antigens. Chem. Biol. 2001, 8, 265-275.
7. Liu, T.; Guo, Z.; Yang, Q.; Sad, S.; Jennings, H. J., Biochemical engineering of surface α2,8 polysialic acid for immunotargeting tumor cells. J. Biol. Chem. 2000, 275, 32832-32836.
8. Lemieux, G. A.; Yarema, K. J.; Jacobs, C. L.; Bertozzi, C. R. Exploiting differences in sialoside expression for selective targeting of MRI contrast reagents. J. Am. Chem. Soc. 1999, 121, 4278-4279.
9. Viswanathan, K.; Lawrence, S.; Hinderlich, S.; Yarema, K. J.; Lee, Y. C.; Betenbaugh, M. Engineering sialic acid synthetic ability into insect cells: Identifying metabolic bottlenecks and devising strategies to overcome them. Biochemistry 2003, 42, 15215-15225.
10. Grossmann, M.; Wong, R.; Teh, N. G.; Tropea, J. E.; East-Palmer, J.; Weintraub, B. D.; Szkudlinski, M. W. Expression of biologically active human thyrotropin (hTSH) in a baculovirus system: effect of insect cell glycosylation on hTSH activity in vitro and in vivo. Endocrinology 1997, 138, 92-100.
11. Ailor, E.; Takahashi, H.; Tsukamoto, Y.; Masuda, K.; Abdul, R. B.; Jarvis, D. L.; Lee, Y. C.; Betenbaugh, M. J. N-Glycan patterns of human transferrin produced in Trichoplusia ni insect cells: effects of mammalian galactosyl-transferase. Glycobiology 2000, 10, 837-847.
12. Lawrence, S. M.; Huddleston, K. A.; Tomiya, N.; Nguyen, N.; Lee, Y. C.; Vann, W. F.; Coleman, T. A.; Betenbaugh, M. J. Cloning and expression of human sialic acid pathway genes to generate CMP-sialic acids in insect cells. Glycoconjugate J. 2001, 18, 205-213.
13. Sarkar, A. K.; Fritz, T. A.; Taylor, W. H.; Esko, J. D. Disaccharide uptake and priming in animal cells: inhibition of sialyl Lewis X by acetylated Gal β1,4GalcNAc β-onaphthalenemethanol. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 3323-3327.
14. Sarkar, A. K.; Rostand, K. S.; Jain, R. K.; Matta, K. L.; Esko, J. D. Fucosylation of disaccharide precursors of sialyl Lewis X inhibit selectin-mediated cell adhesion. J. Biol. Chem. 1997, 272, 25608-25616.
15. Mong, T. K.-K.; Lee, L. V.; Brown, J. R.; Esko, J. D.; Wong, C.-H. Synthesis of N-acetyllactosamine derivatives with variation in the aglycon moiety for the study of inhibition of sialyl Lewis X expression. ChemBioChem 2003, 4, 835-840.
16. Fuster, M. M.; Brown, J. R.; Wang, L.; Esko, J. D. A disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells. Cancer Res. 2003, 63, 2775-2781.
17. Jones, M. B.; Teng, H.; Rhee, J. K.; Baskaran, G.; Lahar, N.; Yarema, K. J. Characterization of the cellular uptake and metabolic conversion of acetylated N-acetylmannosamine (ManNAc) analogues to sialic acids. Biotechnol. Bioeng. 2004, 85, 394-405.
18. Kim, E. J.; Sampathkumar, S.-G.; Jones, M. B.; Rhee, J. K.; Baskaran, G.; Yarema, K. J. Characterization of the metabolic flux and apoptotic effects of O-hydroxyl- and N-acetylmannosamine (ManNAc) analogues in Jurkat (human T-lymphoma-derived) cells. J. Biol. Chem. 2004, 279, 18342-18352.
19. Jacobs, C. L.; Goon, S.; Yarema, K. J.; Hinderlich, S.; Hang, H. C.; Chai, D. H.; Bertozzi, C. R. Substrate specificity of the sialic acid biosynthetic pathway. Biochemistry 2001, 40, 12864-12874.
20. Vermes, I.; Haanen, C.; Steffens-Nakken, H.; Reutelingsperger, C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled Annexin V. J. Immunol. Methods 1995, 184, 39-51.
21. Yarema, K. J.; Goon, S.; Bertozzi, C. R. Metabolic selection of glycosylation defects in human cells. Nat. Biotechnol. 2001, 19, 553-558.
22. Jourdian, G. W.; Dean, L.; Roseman, S. The sialic acids. XI. A periodate-resorcinol method for the quantitative estimation of free sialic acids and their glycosides. J. Biol. Chem. 1971, 246, 430-435.
23. Yarema, K. J. New directions in carbohydrate engineering: A metabolic substrate-based approach to modify the cell surface display of sialic acids. BioTechniques 2001, 31, 384-393.
24. Keppler, O. T.; Horstkorte, R.; Pawlita, M.; Schmidt, C.; Reutter, W. Biochemical engineering of the N-acyl side chain of sialic acid: biological implications. Glycobiology 2001, 11, 11R-18R.
25. Collins, B. E.; Fralich, T. J.; Itonori, S.; Ichikawa, Y.; Schnaar, R. L. Conversion of cellular sialic acid expression from N-acetyl- to N-glycolylneuraminic acid using a synthetic precursor, N-glycolylmannosamine pentaacetate: inhibition of myelin-associated glycoprotein binding to neural cells. Glycobiology 2000, 10, 11-20.
26. Stanley, P.; Raju, T. S.; Bhaumik, M. CHO cells provide access to novel N-glycans and developmentally regulated glycosyltransferases. Glycobiology 1996, 6, 696-699.
27. Susin, S. A. N.; Zamzami, N.; Kroemer, G. Mitochondria as a regulator of apoptosis-doubt no longer. Biochim. Biophys. Acta 1998, 1366, 151-165.
28. Schmitt, E.; Sane, A.-T.; Bertrand, R. Activation and role of caspases in chemotherapy-induced apoptosis. Drug Resist. Updates 1999, 2, 21-29.
29. Tafani, M.; Minechenko, D. A.; Serroni, A.; Farber, J. L. Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by stauroporine. Cancer Res. 2001, 61, 2459-2466.
30. Chung, J. D.; Zabel, C.; Sinskey, A. J.; Stephanopoulos, G. Extension of Sp2/0 hybridoma cell viability through interleukin-6 supplementation. Biotechnol. Bioeng. 1997, 55, 439-446.
31. Mastrangelo, A. J.; Betenbaugh, M. J. Overcoming apoptosis: new methods for improving protein-expression systems. Trends Biotechnol. 1998, 16, 88-95.
32. Simpson, N. H.; Milner, A. E.; Al-Rubeai, M. Prevention of hydridoma cell death by Bcl-2 during sub-optimal culture conditions. Biotechnol. Bioeng. 1997, 54, 1-16.
33. Mastrangelo, A. J.; Hardwick, J. M.; Bex, F.; Betenbaugh, M. J. Part I. Bcl-2 and Bcl-xL limit apoptosis upon infection with alphavirus vectors. Biotechnol. Bioeng. 2000, 67, 544-554.
34. Mastrangelo, A. J.; Hardwick, J. M.; Zou, S.; Betenbaugh, M. J. Part II. Overexpression of Bcl-2 family members enhances survival of mammalian cells in response to various culture insults. Biotechnol. Bioeng. 2000, 67, 555-564.
35. Kim, E. J.; Park, H. J.; Park, T. H. Inhibition of apoptosis by recombinant 30K protein originating from silkworm hemolymph. Biochem. Biophys. Res. Commun. 2003, 308, 523-528.
36. Kim, E. J.; Rhee, W. J.; Park, T. H. Inhibition of apoptosis by a Bombyx mori gene. Biotechnol. Prog. 2004, 20, 324-329.
37. Lasunskaia, E. B.; Fridlianskaia, I. I.; Darieva, Z. A.; Da Silva, M. S.; Kanashiro, M. M.; Margulis, B. A. Transfection of NS0 myeloma fusion partner cells with HSP70 gene results in higher hybridoma yield by improving cellular resistance to apoptosis. Biotechnol. Bioeng. 2003, 81, 496-504.
38. Mercille, S.; Massie, B. Apoptosis-resistant E1B-19K-expressing NS/0 myeloma cells exhibit increased viability and chimeric antibody productivity under perfusion culture conditions. Biotechnol. Bioeng. 1999, 63, 529-543.